10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
PR Newswire —
Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care PLEASANTON, Calif., Jan. 12, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with...